Loading...
Thumbnail Image
Item

The promise of radiotherapy in high-risk non-muscle invasive bladder cancer

Bola, B.
Hoskin, P. J.
Sangar, V.
Choudhury, A.
Citations
Google Scholar:
Altmetric:
Abstract
Global shortages, toxicities, and high levels of incomplete treatment with Bacillus Calmette Guerin (BCG) for non-muscle invasive bladder cancer has resulted in increasing interest in alternative treatments. Radiotherapy is not the standard of care for non-muscle invasive bladder cancer (NMIBC), despite being routinely used in muscle invasive bladder cancer. Modern techniques and advances in technology mean that radiotherapy can be delivered with increased precision in reducing normal tissue damage. Developing novel biomarker approaches, together with combination approaches with radiosensitisers and other systemic treatments, means that radiotherapy could offer greater benefits than current treatments with BCG or surgery. This review summarises the current landscape and future potential of radiotherapy for high-risk NMIBC.
Description
Date
2025
Publisher
Keywords
Type
Article
Citation
Bola B, Hoskin PJ, Sangar V, Choudhury A. The Promise of Radiotherapy in High-Risk Non-Muscle Invasive Bladder Cancer. Cancers (Basel). 2025 Feb 13;17(4). PubMed PMID: 40002223. Pubmed Central PMCID: PMC11853320. Epub 2025/02/26. eng.
Journal Title
Journal ISSN
Volume Title
Embedded videos